Panagora Asset Management Inc Travere Therapeutics, Inc. Transaction History
Panagora Asset Management Inc
- $21 Billion
- Q4 2024
A detailed history of Panagora Asset Management Inc transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 335,162 shares of TVTX stock, worth $6.51 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
335,162
Previous 320,333
4.63%
Holding current value
$6.51 Million
Previous $4.48 Million
30.28%
% of portfolio
0.03%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding TVTX
# of Institutions
214Shares Held
94.3MCall Options Held
1.2MPut Options Held
778K-
Black Rock Inc. New York, NY7.64MShares$148 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$143 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.74MShares$131 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$96.5 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$82.7 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.25B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...